Variable | Moffit cohort | VMP cohort | Melbourne cohort |
Patients (n) | 177 | 117 | 96 |
Male, n (%) | 96 (54) | 60 (51) | 52 (54) |
Female, n (%) | 81 (46) | 57 (49) | 44 (46) |
Age (years) | |||
Median | 66 | 63 | 68 |
Range | 26–92 | 23–94 | 30–92 |
Location, n (%) | |||
Colon | 177 (100) | 84 (72) | 72 (75) |
Rectum | 0 (0) | 33 (28) | 24 (25) |
AJCC stage, n (%) | |||
I | 24 (14) | 17 (15) | 19 (20) |
II | 57 (32) | 38 (21) | 42 (70) |
III | 57 (32) | 40 (34) | 35 (36) |
IV | 39 (22) | 22 (19) | 0 (0) |
Grade, n (%) | |||
1 | 16 (9) | 1 (1) | |
2 | 134 (76) | 63 (54) | |
3 | 27 (15) | 34 (29) | |
NA | 19 (16) | 96 (100) | |
Adjuvant chemotherapy, n (%) | |||
Yes | 82 (46) | 39 (33) | 26 (27) |
No | 82 (46) | 16 (14) | 70 (73) |
NA | 13 (8) | 62 (53) | 0 |
Number of deaths | 72 | 32 | 20* |
Median follow-up (months) | 42.2 | 48.2 | 40.2 |
↵* Recurrence.
AJCC, American Joint Committee on Cancer; NA, not applicable; VMP, Vanderbilt and Max Planck.